State Street Corp Rapt Therapeutics, Inc. Transaction History

State Street Corp

$2.41 Trillion
Q3 2024

A detailed history of State Street Corp transactions in Rapt Therapeutics, Inc. stock. As of the latest transaction made, State Street Corp holds 679,508 shares of RAPT stock, worth $563,991. This represents 0.0% of its overall portfolio holdings.

Number of Shares

679,508

Previous 671,785 1.15%

Holding current value

$563,991

Previous $2.05 Million 33.35%

% of portfolio

0.0%

Previous 0.0%

19 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	BUY	$1.76 - $3.75 $13,592 - $28,961	7,723 Added 1.15%	679,508 $1.37 Million
Q2 2024 Aug 14, 2024	BUY	$2.89 - $9.38 $35,786 - $116,152	12,383 Added 1.88%	671,785 $2.05 Million
Q1 2024 May 15, 2024	SELL	$6.87 - $26.45 $5.46 Million - $21 Million	-795,154 Reduced 54.67%	659,402 $5.92 Million
Q4 2023 Feb 14, 2024	BUY	$11.28 - $25.46 $542,049 - $1.22 Million	48,054 Added 3.42%	1,454,556 $36.1 Million
Q3 2023 Nov 14, 2023	SELL	$16.34 - $24.66 $4.83 Million - $7.29 Million	-295,543 Reduced 17.36%	1,406,502 $23.4 Million
Q2 2023 Aug 14, 2023	BUY	$16.06 - $21.61 $1.01 Million - $1.36 Million	62,999 Added 3.84%	1,702,045 $31.8 Million
Q1 2023 May 15, 2023	SELL	$17.19 - $30.8 $5.19 Million - $9.29 Million	-301,677 Reduced 15.54%	1,639,046 $30.1 Million
Q4 2022 Feb 14, 2023	BUY	$16.28 - $24.6 $10.9 Million - $16.4 Million	666,832 Added 52.35%	1,940,723 $38.4 Million
Q3 2022 Nov 15, 2022	BUY	$17.96 - $30.46 $14.1 Million - $23.9 Million	783,026 Added 159.52%	1,273,891 $30.7 Million
Q2 2022 Aug 15, 2022	SELL	$10.26 - $23.59 $8.79 Million - $20.2 Million	-856,716 Reduced 63.57%	490,865 $8.96 Million
Q1 2022 May 16, 2022	BUY	$17.02 - $40.22 $1.77 Million - $4.17 Million	103,794 Added 8.34%	1,347,581 $29.6 Million
Q4 2021 Feb 14, 2022	BUY	$29.5 - $39.5 $26.5 Million - $35.5 Million	898,950 Added 260.69%	1,243,787 $45.7 Million
Q3 2021 Nov 15, 2021	BUY	$29.86 - $39.47 $2.22 Million - $2.94 Million	74,381 Added 27.5%	344,837 $10.7 Million
Q2 2021 Aug 16, 2021	BUY	$17.99 - $40.02 $1.37 Million - $3.05 Million	76,290 Added 39.29%	270,456 $8.6 Million
Q1 2021 May 17, 2021	BUY	$16.0 - $24.46 $12,704 - $19,421	794 Added 0.41%	194,166 $4.31 Million
Q4 2020 Feb 16, 2021	BUY	$15.89 - $40.87 $111,929 - $287,888	7,044 Added 3.78%	193,372 $3.82 Million
Q3 2020 Nov 10, 2020	BUY	$21.6 - $37.5 $180,986 - $314,212	8,379 Added 4.71%	186,328 $6 Million
Q2 2020 Aug 14, 2020	BUY	$14.16 - $32.85 $2.18 Million - $5.05 Million	153,816 Added 637.37%	177,949 $5.16 Million
Q1 2020 May 11, 2020	BUY	$11.86 - $48.86 $286,217 - $1.18 Million	24,133 New	24,133 $513,000

Others Institutions Holding RAPT

# of Institutions

104

Shares Held

27.1M

Call Options Held

26.7K

Put Options Held

2.4K

View Full List

About RAPT Therapeutics, Inc.

Ticker RAPT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 29,656,600
Market Cap $24.6M
Description
RAPT Therapeutics, Inc., a clinical-stage immunology-based biopharmaceutical company, focuses on discovering, developing, and commercializing oral small molecule therapies for patients with unmet needs in oncology and inflammatory diseases. Its lead inflammation drug candidate is RPT193, a C-C motif chemokine receptor 4 (CCR4) antagonist that se...

More about RAPT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of State Street Corp, based on Form 13F filings with the SEC.

News

Stay updated on State Street Corp with notifications on news.

Account

State Street Corp Rapt Therapeutics, Inc. Transaction History